OTC Markets EXMKT - Delayed Quote USD
Notable Labs, Ltd. (NTBLQ)
0.0001
0.0000
(0.00%)
At close: April 24 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
313
310
8
285
Cost of Revenue
197
197
--
--
Gross Profit
116
113
8
285
Operating Expense
15,486
14,770
12,932
17,199
Operating Income
-15,370
-14,657
-12,924
-16,914
Other Income Expense
4,828
3,393
-1,483
862
Pretax Income
-10,542
-11,264
-14,407
-16,052
Net Income Common Stockholders
-10,542
-11,264
-14,407
-16,052
Diluted NI Available to Com Stockholders
-10,542
-11,264
-14,407
-16,052
Basic EPS
-1.09
-3.41
-1.61
-1.80
Diluted EPS
-1.09
-3.41
-1.61
-1.80
Basic Average Shares
9,674.4960
3,302.8180
8,936.4480
8,936.4480
Diluted Average Shares
9,674.4960
3,302.8180
8,936.4480
8,936.4480
Total Operating Income as Reported
-15,370
-14,657
-12,924
-16,914
Total Expenses
15,683
14,967
12,932
17,199
Net Income from Continuing & Discontinued Operation
-10,542
-11,264
-14,407
-16,052
Normalized Income
-14,099
-16,214
-11,892
-16,052
EBIT
-15,370
-14,657
-12,924
-16,914
EBITDA
-15,116
-14,400
-12,601
-16,588
Reconciled Cost of Revenue
197
197
--
--
Reconciled Depreciation
254
257
323
326
Net Income from Continuing Operation Net Minority Interest
-10,542
-11,264
-14,407
-16,052
Total Unusual Items Excluding Goodwill
3,557
4,950
-2,515
--
Total Unusual Items
3,557
4,950
-2,515
--
Normalized EBITDA
-18,673
-19,350
-10,086
-16,588
12/31/2021 - 10/17/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APLM Apollomics, Inc.
6.22
-1.51%
ABP Abpro Corporation
0.3310
+2.10%
RNTX Rein Therapeutics Inc.
1.8300
+0.55%
CYCN Cyclerion Therapeutics, Inc.
3.0100
+2.03%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2290
-0.52%
CMPX Compass Therapeutics, Inc.
2.1200
+2.42%
IGMS IGM Biosciences, Inc.
1.3800
-0.72%
ANRO Alto Neuroscience, Inc.
2.2800
+0.44%
AVTE Aerovate Therapeutics, Inc.
2.7200
-0.73%
HOPHF Hemogenyx Pharmaceuticals Plc
0.0400
0.00%